Latest revenue
$33.7M
as of 2026-03-31
Latest net income
$1.0M
as of 2026-03-31
Net margin
3.0%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $195.0M
- Enterprise value
- $195.0M
- P/E (trailing)
- 29.4×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $11.04
- 52-wk low
- $5.08
- Beta
- —
- Shares out
- 20.2M
5-year trend
About INFU
Business description and risk factors will appear here once INFU's latest filing is fully ingested.
Profitability
Gross margin
56.0%
7.2%Operating margin
8.3%
62.6%Net margin
4.6%
165.7%Return on equity
11.6%
157.8%Return on assets
6.6%
191.2%Leverage
Debt / equity
0.75×
23.1%Long-term debt / equity
0.34×
25.0%Debt / assets
43.0%
13.2%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $33.7M | -3.0% | $1.0M | +480.9% | 3.0% |
Q4 2025 2025-12-31 | $36.2M | +7.0% | $2.3M | -5.6% | 6.4% |
Q3 2025 2025-09-30 | $36.5M | +3.3% | $2.3M | +60.0% | 6.2% |
Q2 2025 2025-06-30 | $36.0M | +6.8% | $2.3M | +690.4% | 6.5% |
Q1 2025 2025-03-31 | $34.7M | +8.5% | $-267.0K | +76.0% | -0.8% |
Q4 2024 2024-12-31 | $33.8M | — | $2.4M | — | 7.2% |
Q3 2024 2024-09-30 | $35.3M | +10.7% | $1.4M | +104.9% | 4.0% |
Q2 2024 2024-06-30 | $33.7M | +6.2% | $-395.0K | -455.9% | -1.2% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Surgical & Medical Instruments & Apparatus · SIC 3841
Your notes
Keep private notes on INFU — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$160.7K
Insider selling
$55.6K
Net activity
+$105.1K
Distinct insiders
5
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns INFU
Institutional value
$65.6M
Total shares held
7.9M
Distinct holders
48
-52 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | Minerva Advisors LLC | 1.2M | $11.1M | +125.4K (+11.6%) | Added |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 860.3K | $7.9M | — | New |
| 3 | First Eagle Investment Management, LLC | 721.4K | $6.7M | -30.0K (-4.0%) | Trimmed |
| 4 | BlackRock, Inc. | 616.6K | $5.7M | +6.7K (+1.1%) | Added |
| 5 | DIMENSIONAL FUND ADVISORS LP | 594.3K | $5.5M | +33.4K (+6.0%) | Added |
| 6 | HEARTLAND ADVISORS INC | 510.0K | $4.7M | +10.0K (+2.0%) | Added |
| 7 | Hillsdale Investment Management Inc. | 452.4K | $4.2M | +5.0K (+1.1%) | Added |
| 8 | ESSEX INVESTMENT MANAGEMENT CO LLC | 299.3K | $2.8M | +5.3K (+1.8%) | Added |
| 9 | Truffle Hound Capital, LLC | 230.0K | $2.1M | +0 (+0.0%) | No change |
| 10 | North Star Investment Management Corp. | 182.0K | $1.7M | +153.0K (+527.6%) | Added |
| 11 | Russell Investments Group, Ltd. | 130.1K | $1.2M | -90.2K (-41.0%) | Trimmed |
| 12 | JANE STREET GROUP, LLC | 127.3K | $1.2M | -30.9K (-19.5%) | Trimmed |
| 13 | VANGUARD FIDUCIARY TRUST CO | 122.0K | $1.1M | — | New |
| 14 | WHITE PINE CAPITAL LLC | 115.6K | $1.1M | +13.9K (+13.7%) | Added |
| 15 | BNP PARIBAS FINANCIAL MARKETS | 110.6K | $1.0M | +19.4K (+21.2%) | Added |
| 16 | SEI INVESTMENTS CO | 104.8K | $966.9K | +57.9K (+123.8%) | Added |
| 17 | GLOBEFLEX CAPITAL L P | 80.0K | $738.0K | +0 (+0.0%) | No change |
| 18 | Connor, Clark & Lunn Investment Management Ltd. | 71.4K | $658.7K | -6.1K (-7.9%) | Trimmed |
| 19 | Bank of New York Mellon Corp | 65.1K | $600.7K | -11.9K (-15.4%) | Trimmed |
| 20 | ARS Investment Partners, LLC | 48.8K | $450.6K | +765 (+1.6%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once INFU's latest filing finishes processing.